Bristol Myers Squibb says it will buy drug developer RayzeBio for about $4.1 billion.
Share:
More In Business
Why Energy Prices Are Becoming a Key Economic Issue Ahead of November
Rob Schroeder of MarketWatch breaks down rising energy costs, $6 diesel, the “Trump Dividend” and how the economy could factor into the 2026 midterms.
Sports Betting Is Changing Fast. BetMGM CEO On The Fight For Bettors
BetMGM CEO Adam Greenblatt breaks down football betting, prediction markets, live bets and how technology is reshaping the fight for sports bettors.
Fed Rate Cut In Focus: Is Inflation Too Hot For Powell To Move?
Chris Versace breaks down the mixed inflation and jobs data facing the Fed and what this week’s rate decision could mean for markets and 2027.
How PopSockets Went From A Garage Project To A Household Name
PopSockets founder David Barnett explains how a simple idea became 300 million products, major partnerships and a global phone-accessory brand.
Hollywood’s $4.7 Billion Summer: Is The Movie Business Back?
Seth Schachner, Managing Director at Strat Americas, explains what fueled Hollywood’s $4.7 billion summer and whether movie theaters are truly back.
Trump Makes A Crypto Concession, But The Senate Fight Isn’t Over
President Trump has agreed to new ethics provisions aimed at clearing a major cryptocurrency bill through the Senate.
The Real Cost Of Owning A Car Today
New car owner analysis from Insurify finds drivers spend an average of $5,851 a year on insurance, gas and maintenance alone, separate from financing costs.
Oil Surges As Saudi Arabia Loses A Key Route Around Hormuz
Oil prices are climbing again after Saudi Arabia shut down a critical pipeline that has served as a major alternative route around the Strait of Hormuz.
Canada Makes A Big Pitch For Global Investment
Canada is rolling out the welcome mat for some of the world’s biggest investors as Prime Minister Mark Carney tries to attract billions of dollars.
